表紙
市場調査レポート

Tetra Discovery Partners LLC:製品パイプライン分析

Tetra Discovery Partners LLC - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 319998
出版日 ページ情報 英文 22 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
Tetra Discovery Partners LLC:製品パイプライン分析 Tetra Discovery Partners LLC - Product Pipeline Review - 2015
出版日: 2015年12月16日 ページ情報: 英文 22 Pages
概要

Tetra Discovery Partners LLC は、精神疾患や神経疾患の治療薬を発見と開発に力を入れているバイオテクノロジー企業です。 構造情報に基づく薬剤設計の科学的アプローチを用いてホスホジエステラーゼ4のサブタイプに対するアロステリック阻害剤を開発しています。また、同社のパイプラインは主にアルツハイマー病、鬱病、外傷性脳損傷治療の3つの薬物候補で構成されており、主要な化合物には初期から中度のアルツハイマー病の記憶喪失治療用に設計されたものがあります。

当レポートでは、Tetra Discovery Partners LLCにおける治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Tetra Discovery Partners LLCの基本情報

  • Tetra Discovery Partners LLCの概要
  • 主要情報
  • 企業情報

Tetra Discovery Partners LLC:R&Dの概要

  • 主な治療範囲

Tetra Discovery Partners LLC:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Tetra Discovery Partners LLC:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

Tetra Discovery Partners LLC:開発段階が不明のパイプライン製品

  • 開発段階が不明の製品/併用療法モダリティ

Tetra Discovery Partners LLC:薬剤プロファイル

  • Small Molecule to Inhibit PDE4 for Alzheimer's Disease
  • Small Molecule to Inhibit PDE4 for Depression
  • Small Molecule to Inhibit PDE4 for Traumatic Brain Injury
  • Small Molecules to Inhibit PDE4D for Schizophrenia

Tetra Discovery Partners LLC:パイプライン分析

  • 標的別
  • 分子タイプ別
  • 作用機序別

Tetra Discovery Partners LLC:最近のパイプライン動向

Tetra Discovery Partners LLC:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07882CDB

Summary

Global Markets Direct's, 'Tetra Discovery Partners LLC - Product Pipeline Review - 2015', provides an overview of the Tetra Discovery Partners LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Tetra Discovery Partners LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Tetra Discovery Partners LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Tetra Discovery Partners LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Tetra Discovery Partners LLC's pipeline products

Reasons to buy

  • Evaluate Tetra Discovery Partners LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Tetra Discovery Partners LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Tetra Discovery Partners LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Tetra Discovery Partners LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tetra Discovery Partners LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Tetra Discovery Partners LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Tetra Discovery Partners LLC Snapshot
    • Tetra Discovery Partners LLC Overview
    • Key Information
    • Key Facts
  • Tetra Discovery Partners LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Tetra Discovery Partners LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Tetra Discovery Partners LLC - Pipeline Products Glance
    • Tetra Discovery Partners LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
    • Tetra Discovery Partners LLC - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Tetra Discovery Partners LLC - Drug Profiles
    • BPN-14770
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DG-071
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • T-094
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit PDE4D for Schizophrenia
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Tetra Discovery Partners LLC - Pipeline Analysis
    • Tetra Discovery Partners LLC - Pipeline Products by Target
    • Tetra Discovery Partners LLC - Pipeline Products by Molecule Type
    • Tetra Discovery Partners LLC - Pipeline Products by Mechanism of Action
  • Tetra Discovery Partners LLC - Recent Pipeline Updates
  • Tetra Discovery Partners LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Tetra Discovery Partners LLC, Key Information
  • Tetra Discovery Partners LLC, Key Facts
  • Tetra Discovery Partners LLC - Pipeline by Indication, 2015
  • Tetra Discovery Partners LLC - Pipeline by Stage of Development, 2015
  • Tetra Discovery Partners LLC - Monotherapy Products in Pipeline, 2015
  • Tetra Discovery Partners LLC - Preclinical, 2015
  • Tetra Discovery Partners LLC - Discovery, 2015
  • Tetra Discovery Partners LLC - Unknown, 2015
  • Tetra Discovery Partners LLC - Pipeline by Target, 2015
  • Tetra Discovery Partners LLC - Pipeline by Molecule Type, 2015
  • Tetra Discovery Partners LLC - Pipeline Products by Mechanism of Action, 2015
  • Tetra Discovery Partners LLC - Recent Pipeline Updates, 2015

List of Figures

  • Tetra Discovery Partners LLC - Pipeline by Top 10 Indication, 2015
  • Tetra Discovery Partners LLC - Pipeline by Stage of Development, 2015
  • Tetra Discovery Partners LLC - Monotherapy Products in Pipeline, 2015
  • Tetra Discovery Partners LLC - Pipeline by Top 10 Target, 2015
  • Tetra Discovery Partners LLC - Pipeline by Top 10 Molecule Type, 2015
  • Tetra Discovery Partners LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top